Search

Your search keyword '"Tahirkheli, Naeem"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Tahirkheli, Naeem" Remove constraint Author: "Tahirkheli, Naeem"
27 results on '"Tahirkheli, Naeem"'

Search Results

4. ISCHEMIC RISK MATTERS - RISK STRATIFICATION IN HIGH BLEEDING RISK (HBR) PATIENTS IMPLANTED WITH THE SYNERGY STENT: A POST-HOC ANALYSIS OF THE EVOLVE SHORT DAPT STUDY

5. SINGLE CENTER CLINICAL EXPERIENCE WITH HYBRID CONVERGENT ABLATION AND IMPACT ON ATRIAL FIBRILLATION BURDEN AS DETERMINED BY CARDIAC RHYTHM MANAGEMENT DEVICES.

6. Left Main Coronary Artery Stenosis following Bentall Procedure: A case report.

7. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

8. Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials

9. Primary Results of the EVOLVE Short DAPT Study

10. TCT CONNECT-381 Predictors of Ischemic and Bleeding Outcomes in High Bleeding Risk Patients Implanted With the SYNERGY Stent—A Post Hoc Analysis From the EVOLVE Short DAPT Study

11. SAFETY OF ABBREVIATED DAPT IN HIGH BLEEDING RISK PATIENTS ON ANTICOAGULANTS OR AGE ≥75 YEARS AFTER PCI WITH THE SYNERGY STENT: A SUBGROUP ANALYSIS OF THE EVOLVE SHORT DAPT STUDY

12. Multicenter Validation of the Diagnostic Accuracy of a Blood-Based Gene Expression Test for Assessing Obstructive Coronary Artery Disease in Nondiabetic Patients

14. EFFICACY OF DUAL ANTI-PLATELET THERAPY IN CORONARY ARTERY BYPASS GRAFT PATIENTS WITH STABLE ISCHEMIC HEART DISEASE

15. Ertugliflozin and Slope of Chronic eGFR

17. TCT-841 Baseline characteristics and 3-month outcomes of the EVOLVE Short DAPT Trial: A prospective investigation of abbreviated antiplatelet therapy in high bleeding risk patients treated with a thin-strut bioabsorbable polymer-coated, everolimus-eluting coronary stent

18. THE DIAGNOSTIC YIELD OF CORONARY ANGIOGRAPHY REMAINS LOW, DESPITE PRIOR MYOCARDIAL PERFUSION IMAGING TESTING, IN PATIENTS WITH SUSPECTED OBSTRUCTIVE CORONARY ARTERY DISEASE: RESULTS OF THE PREDICT (PERSONALIZED RISK EVALUATION AND DIAGNOSIS IN THE CORONARY TREE) TRIAL

19. A PERIPHERAL BLOOD GENE EXPRESSION SCORE FOR CORONARY ARTERY DISEASE IN NON-DIABETIC PATIENTS IDENTIFIES PATIENTS AT LOW RISK FOR MAJOR CARDIOVASCULAR EVENTS AND INTERVENTIONAL PROCEDURES IN THE NEXT 12 MONTHS

20. Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure∗∗The content of this manuscript is not associated with any financial interest or other relations that could lead to a conflict of interest.

22. Abstract 11691: Three Months of Dual Antiplatelet Therapy is Optimal Time for Mortality and Morbidity Benefit Post Coronary Artery Bypass Grafting - Results of an In-depth, Retrospective Review of a Large Series of Patients From a Single Center

27. MULTI-CENTER, OPEN-LABEL STUDY OF THE EFFICACY AND SAFETY OF ETRIPAMIL NASAL SPRAY SELF-ADMINISTERED FOR MULTIPLE EPISODES OF SYMPTOMATIC SUPRAVENTRICULAR TACHYCARDIA WITHOUT SUPERVISION (PHASE 3, NODE-303).

Catalog

Books, media, physical & digital resources